Andrew G. Long

Andy was appointed Executive Vice President, Chief Executive Officer, Products & Healthcare Services, effective October 12, 2022. Prior to that, Andy was Executive Vice President & Chief Financial Officer, since joining the Company in November 2019. Previously, Andy served as the Chief Executive Officer of Insys Therapeutics, Inc. (“Insys”) from April 2019 to November 8, 2019 and as the Chief Financial Officer of Insys from August 2017 until April 2019. Prior to joining Insys, Mr. Long served as senior vice president of Global Finance at Patheon, a pharmaceutical company, from 2015 to 2017. Prior to Patheon, Mr. Long served as Vice President of Finance for multiple divisions at Thermo Fisher Scientific from 2006 until 2015.